ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
6 hedge funds and large institutions have $2.2M invested in ENVUE MEDICAL INC NEW in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
16% more capital invested
Capital invested by funds: $1.91M → $2.2M (+$297K)
1.24% more ownership
Funds ownership: 13.17% → 14.41% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$98.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
FEED Hedge Fund Activity: Q1 2019 in Review
6 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q1 2019, worth a combined $2.2M — up 16% from $1.91M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FEED positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $98.6K. The largest seller was UBS Group, cutting an estimated $16K.
- 6 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q1 2019, up from 5 in Q4 2018.
- Funds reported $2.2M of ENVUE MEDICAL INC NEW stock for Q1 2019, up 16% quarter-over-quarter.
- 1 fund opened new ENVUE MEDICAL INC NEW positions in Q1 2019 and 0 closed out, a net change of +1 holder.
- The largest ENVUE MEDICAL INC NEW buyer in Q1 2019 was Citadel Advisors, an estimated $98.6K added.
- The largest ENVUE MEDICAL INC NEW seller in Q1 2019 was UBS Group, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2019.